ETF Innovators

About I am a pharmacist, freelance writer, and index developer for ETF Innovators, LLP, which creates new global equity indexes for licensing and commercialization as exchange-traded funds. I have been investing since August 1997 and freelance writing for investors since April 2007 with a focus on the healthcare sector and ETFs. I hold Doctor of Pharmacy (2003) and Bachelor of Science – Biology Major (1998) degrees from the University of Pittsburgh and worked in the pharmaceutical industry for Wyeth prior to pharmacy school. I am also an avid runner since 1992 and have completed 18 marathons (26.2 miles) with a personal best time of 2 hours, 54 minutes. I can be contacted by email at mikehav[at]ymail[dot]com. My LinkedIn Profile: http://www.linkedin.com/in/mikehav Clear Vision Advisors: http://www.clearvisionadvisors.com

Website

http://etfinnovators.com

Last 50 Posts by ETF Innovators:

• »Upcoming FDA Advisory Panel Meetings
  09 Mar 2009 in Exchange Traded Funds
  
• »Healthcare Investing Trends for ‘09 and Beyond
  06 Feb 2009 in Exchange Traded Funds
  
• »ThermoGenesis: A Stealth Stem Cell Play
  31 Jan 2009 in Exchange Traded Funds
  
• »President Obama Urges Greener Vehicles
  26 Jan 2009 in Exchange Traded Funds
  
• »Trading the Exchanges: Buying CME Group
  26 Dec 2008 in Exchange Traded Funds
  
• »Carbon Trading: Investing in the Thin Air
  15 Dec 2008 in Exchange Traded Funds
  
• »Home Diagnostics Offers Value to Diabetics and Investors
  15 Dec 2008 in Exchange Traded Funds
  
• »AirShares (ASO) Carbon Fund Begins Trading Monday 12/15/08
  14 Dec 2008 in Exchange Traded Funds
  
• »Tender Offer for Taro Pharma Tarries Along
  10 Dec 2008 in Exchange Traded Funds & India & Israel
  
• »Look For Laggards After Latest Market Rally
  08 Dec 2008 in Exchange Traded Funds
  
• »Pittsburgh Marathon Returns on Sunday 5/3/09
  06 Dec 2008 in Exchange Traded Funds
  
• »Full FDA Calendar of Decision Dates
  29 Nov 2008 in Exchange Traded Funds
  
• »A New Micro-Cap Bio-Pharma Index
  28 Nov 2008 in Biotech & Exchange Traded Funds
  
• »Moving Made Easy at MoveMe.com
  27 Nov 2008 in Exchange Traded Funds
  
• »Health Cost Containment Index: Expanding into India, Impax Labs Set to Re-List
  26 Nov 2008 in Exchange Traded Funds
  
• »Stock Picks for Healthy Returns
  24 Nov 2008 in Exchange Traded Funds
  
• »Achillion Pharma: Funding in Place to Advance HCV Pipeline
  24 Nov 2008 in Exchange Traded Funds
  
• »Analysis of Generic Drug Companies from India
  24 Nov 2008 in Exchange Traded Funds & India
  
• »Emerging Biotech Pharma Index: 36 More Cos.
  23 Nov 2008 in Biotech & Exchange Traded Funds
  
• »UpDown Virtual Investing: Earn Real Money with Zero Risk
  23 Nov 2008 in Exchange Traded Funds
  
• »A New Global Healthcare Composite Index
  23 Nov 2008 in Exchange Traded Funds
  
• »RD Leads to Higher Returns for Top 20 Health Innovators
  23 Nov 2008 in Biotech & Exchange Traded Funds
  
• »Defensive Stock Opportunities Outside of Healthcare
  20 Nov 2008 in Exchange Traded Funds
  
• »Former Wall Street Favorites Sink to Single Digits
  19 Nov 2008 in Exchange Traded Funds
  
• »An Index of Top Rated Global Transport Companies
  16 Nov 2008 in Exchange Traded Funds
  
• »ETFI Health Innovators Index: Does R&D Lead to Higher Stock Prices?
  12 Nov 2008 in Exchange Traded Funds
  
• »Stock Market News: Monday 10-November
  10 Nov 2008 in Exchange Traded Funds
  
• »ETFI Global Railroad PerformIdex: Stock Prices Adjust to Lower Volumes
  08 Nov 2008 in Exchange Traded Funds
  
• »ETFI Global Healthcare Sector PerformIdex
  08 Nov 2008 in Exchange Traded Funds
  
• »Hospitals Hoping for Increased Insurance Coverage
  08 Nov 2008 in Exchange Traded Funds
  
• »A Backlog of Decisions is Building at the FDA
  07 Nov 2008 in Exchange Traded Funds
  
• »Teva Beats on Profits: A Biogeneric Boon in ‘09?
  05 Nov 2008 in Market Commentary
  
• »Obama-Care Focused on Preventive Medicine
  05 Nov 2008 in Exchange Traded Funds
  
• »Auto Makers Are Out Of Gas
  02 Nov 2008 in Exchange Traded Funds
  
• »Cosmetic & Reconstructive Medicine Companies Outpace the Healthcare Sector
  01 Nov 2008 in Exchange Traded Funds
  
• »Health Benefit Providers Need a Check-Up
  01 Nov 2008 in Exchange Traded Funds
  
• »Warren Buffett Is Still Riding the Rails
  30 Oct 2008 in Exchange Traded Funds
  
• »Biotech Blues: Four Stocks on Sale with Hope
  25 Oct 2008 in Exchange Traded Funds
  
• »Six Healthcare Stocks on Sale
  24 Oct 2008 in Exchange Traded Funds
  
• »Abbott Labs Still Expects TriLipix Approval in 4Q08
  24 Oct 2008 in Exchange Traded Funds
  
• »Expanding Defensive Growth Index into Europe
  22 Oct 2008 in Exchange Traded Funds
  
• »More Pain to Come from the FDA?
  22 Oct 2008 in Exchange Traded Funds
  
• »Amgen Exceeds Expectations, Again
  22 Oct 2008 in Exchange Traded Funds
  
• »An Earnings Encore for Amgen?
  22 Oct 2008 in Exchange Traded Funds
  
• »Head of Retail Ventures is Bullish on the Stock
  21 Oct 2008 in Exchange Traded Funds
  
• »Pfizer Beats on Profits with Aggressive Cost Cutting
  21 Oct 2008 in Exchange Traded Funds
  
• »The Timber Trade: A New Commodity Pool Fund Idea
  20 Oct 2008 in Exchange Traded Funds
  
• »FDA Action Heats Up Before Year-End
  20 Oct 2008 in Exchange Traded Funds
  
• »A Defensive Growth Stock Index
  20 Oct 2008 in Exchange Traded Funds
  
• »Index of Market Cap Leaders by Nation Posts Decline
  20 Oct 2008 in Exchange Traded Funds